BusinessFinTechFunding

Tollys: Raises Over €1.5M from Bpifrance

Tollys: Raises Over €1.5M from Bpifrance

  • Funding consists of 50% non-dilutive funding and 50% long-term loans
  • The company will use the funding for the preclinical development of TL-532 in cancer immunotherapy
  • In May 2020, Tollys closed a round of financing totaling €2.3m ($2.5M)
  • Founded in 2015 by Philippe Guillot-Chêne, chief business officer, and Vincent Charlon, chief executive officer
  • Then the company is pioneering TL-532, a new cancer immunotherapy to treat various types of cancer
  • Tollys discovered and patented a family of TLR3 agonists and selected TL-532 as its lead-candidate
Previous article
Aldi Nord: Selected Fiserv to enable all in-store card payments
Next article
Mission Therapeutics: Raises $15M in Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

WealthCom Secures $65M Funding Boost for Expansion

The investment aims to enhance service offerings and accelerate growth.Highlights: WealthCom raises $65 million in Series B funding.New...
FinTech

Financial Health Tools Could Unlock $5B in SME Lending

CFIT report highlights the potential of financial hygiene tools for small businesses.Highlights: CFIT report suggests financial health tools...
FinTech

Coinbase Strengthens UK Crypto Borrowing Options for Customers

Users can now borrow against their cryptocurrency holdings in the UK.Highlights: Coinbase now allows UK customers to borrow...
FinTech

Chase UK Appoints Monzo’s Malani as CEO, Strengthening Leadership Team

Former Monzo executive will lead Chase UK's growth strategy.Highlights: Chase UK appoints Monzo veteran Malani as CEO.This move...